Sanofi escapes €116 million damages claim in France

A French court has dismissed as time-barred a follow-on damages claim against Sanofi, as the claimant’s role in the competition authority’s investigation showed it knew about the drugmaker’s illegal conduct before an infringement decision was issued.


Get unlimited access to all Global Competition Review content